# Virgin Coconut Oil (VCO) as a Potential Adjuvant Therapy in COVID-19 Patients

> **NCT04594330** · PHASE2 · UNKNOWN · sponsor: **Gadjah Mada University** · enrollment: 60 (estimated)

## Conditions studied

- Coronavirus Infections

## Interventions

- **DRUG:** virgin coconut oil (VCO)
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT04594330
- **Lead sponsor:** Gadjah Mada University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2020-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04594330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04594330, "Virgin Coconut Oil (VCO) as a Potential Adjuvant Therapy in COVID-19 Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04594330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*